ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,282.70
0.13%
US Tech 100
17,825.60
0.33%
Dow Jones
39,142.23
-1.33%
Brent Oil
67.075
0.00%
Bitcoin
84,626.41
-0.35%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. TuHURA Biosciences Inc (HURA) Quote

TuHURA Biosciences Inc

TuHURA Biosciences Inc (HURA)

Global X Uranium Index ETF
4.15
0.01
(0.24%)
Closed April 18 4:00PM
Delayed by 15 minutes
4.00
-0.15
(-3.61%)
After Hours: 7:12PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
4.00
Bid
4.00
Ask
4.15
Volume
118,034
3.91 Day's Range 4.25
1.80 52 Week Range 7.93
Market Cap
174.722M
Previous Close
4.14
Open
4.17
Last Trade
570
@
4
(formt)
Last Trade Time
Financial Volume
$ 486,125
VWAP
4.1185
Average Volume (3m)
230,264
Shares Outstanding
43,680,397
Dividend Yield
-
PE Ratio
-21.33
Earnings Per Share (EPS)
-0.19
Revenue
-
Net Profit
-8.5M

About TuHURA Biosciences Inc

TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It ... TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase III registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first line treatment for advanced Merkel cell carcinoma. In addition, the Company is leveraging its Delta receptor technology to develop novel bi-functional antibody drug conjugates (ADCs), targeting myeloid derived suppressor cells to inhibit their immune suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. Its IFx platform technology utilizes a proprietary plasmid DNA (pDNA) or messenger RNA (mRNA). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.kintara.com
Headquarters
Reno, Nevada, USA
Founded
-
TuHURA Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HURA. The last closing price for TuHURA Biosciences was $4.14. Over the last year, TuHURA Biosciences shares have traded in a share price range of $ 1.80 to $ 7.93.

TuHURA Biosciences currently has 43,680,397 shares outstanding. The market capitalization of TuHURA Biosciences is $180.84 million. TuHURA Biosciences has a price to earnings ratio (PE ratio) of -21.33.

Ask ADVFN Intelligence (AI)

HURA Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.061.522842639593.944.253.651744034.13165588CS
40.3710.19283746563.634.252.872763833.67040109CS
12-0.66-14.16309012884.665.271.82302643.65562672CS
26-2.55-38.93129770996.557.931.82653104.55403211CS
52-2.55-38.93129770996.557.931.82653104.55403211CS
156-2.55-38.93129770996.557.931.82653104.55403211CS
260-2.55-38.93129770996.557.931.82653104.55403211CS

HURA - Frequently Asked Questions (FAQ)

What is the current TuHURA Biosciences share price?
The current share price of TuHURA Biosciences is $ 4.00
How many TuHURA Biosciences shares are in issue?
TuHURA Biosciences has 43,680,397 shares in issue
What is the market cap of TuHURA Biosciences?
The market capitalisation of TuHURA Biosciences is USD 180.84M
What is the 1 year trading range for TuHURA Biosciences share price?
TuHURA Biosciences has traded in the range of $ 1.80 to $ 7.93 during the past year
What is the PE ratio of TuHURA Biosciences?
The price to earnings ratio of TuHURA Biosciences is -21.33
What is the reporting currency for TuHURA Biosciences?
TuHURA Biosciences reports financial results in USD
What is the latest annual profit for TuHURA Biosciences?
The latest annual profit of TuHURA Biosciences is USD -8.5M
What is the registered address of TuHURA Biosciences?
The registered address for TuHURA Biosciences is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
What is the TuHURA Biosciences website address?
The website address for TuHURA Biosciences is www.kintara.com
Which industry sector does TuHURA Biosciences operate in?
TuHURA Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSGMMotorsport Games Inc
$ 2.69
(140.18%)
37M
SXTCChina SXT Pharmaceuticals Inc
$ 2.11
(113.37%)
51.73M
ADGMAdagio Medical Holdings Inc
$ 1.68
(81.98%)
115.48M
PNBKPatriot National Bancorp Inc
$ 3.28
(73.54%)
1.57M
RTCBaijiayun Group Ltd
$ 0.3601
(67.49%)
187.02M
LXEHLixiang Education Holding Company Ltd
$ 8.25
(-64.11%)
1.55M
CLIKClick Holdings Ltd
$ 0.355
(-48.18%)
13.52M
IOTRiOThree Ltd
$ 1.1409
(-38.33%)
3.93M
FMTOFemto Technologies Inc
$ 0.0191
(-35.47%)
198.4M
SISIShineco Inc
$ 0.5809
(-35.07%)
824.91k
DMNDamon Inc
$ 0.0034
(9.68%)
409.39M
STSSSharps Technology Inc
$ 0.03195
(20.57%)
391.8M
SUNESUNation Energy Inc
$ 0.0176
(-10.20%)
349.4M
NVDANVIDIA Corporation
$ 101.49
(-2.87%)
292.48M
HTZHertz Global Holdings Inc
$ 8.205
(43.70%)
266.91M

Discussion

View Full Feed
DimesForShares DimesForShares 2 minutes ago
I'm only talking about the company after it changed to DJT.  That happened last year.
DJT
TexasMarvL TexasMarvL 3 minutes ago
I bet Keith doesn't want to sell the Cameron project.   
Rainy River mine struggles to stay open just 88 km away.  BTW, 88 km = 55 miles.  
I have watched enough Keith videos.He said First Majestic likes to buy existing production properties that might benefit from new management and a
FFMGF
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 3 minutes ago
Dr. Martin Makary, Trump's new FDA commissioner, has ordered that "Big Pharma" will no longer be allowed on AdComs.
In the past, the large pharma companies were allowed a representative on these advisory panels when new drugs/treatments were decided. That allowed them the opportunity to torpe
AVXL
noshorthere noshorthere 3 minutes ago
Hey, Stay Humble, you're the MOASS (Mother Of All Stupid Sh*ts).😬

How about I repeat-post that after every one of your Stupid Sh*t repeat-posts?😃
DJT
pepeoil pepeoil 4 minutes ago
I hope Emil doesn’t partner it this trash. He has several judgments from stiffing the merchant cash advance people

https://iapps.courts.state.ny.us/nyscef/ViewDocument?docIndex=OS_PLUS_Rgz5UXf3WGTPSe7G6kQ==
TWOH
Dingbatt Dingbatt 4 minutes ago
Jay tee
the OTC is under federal regulations cleared by Depository Trust and regulated by the SEC watching Trump remove DEI and putting in a Crypto friendly head as well as getting rid of Gary Gensler was a plus but you are right about those excessive reverse splits not one has worked so they
RNVA
mascale mascale 4 minutes ago
How this can work: (Per Google AI). . ."going to a hair salon can be considered a spending on experiences. While the core service is a physical change (your hair), it also involves a significant element of personal care and pampering, which contributes to an overall experiential feeling. Salons are
AAGC
Triple nickle Triple nickle 4 minutes ago
STEM .3729 still holding up yesterdays 
SkeBallLarry SkeBallLarry 4 minutes ago
Good & Sunny Good-Friday to yew, TreeMan .. !!
GetSeriousOK GetSeriousOK 4 minutes ago
None of the foot stuff is new.

Missed ya though. I've always loved the way you start with "NO WORD SALADS" and then dish up a huge bowl of word salad.

And you're still serving up the NOPAIN Pump! Such tenacity! You might want to take your own advice, though, and "Do yo
BIEL
Perk_Idaho Perk_Idaho 4 minutes ago
That image is photoshopped, zoom in on the text areas, like total shares held. You can see pixelating around it and the faint image of how it was cut (box around it) from another document.
NWBO
PegnVA PegnVA 5 minutes ago
The convicted felon is just a big mouth - it's what his base likes.
VVVVVV VVVVVV 5 minutes ago
Seems like we were all lead on to believe Emil could close the deal but, apparently the defendants have called his bluff and are going to try to get all this dismissed. Kinda risky for both parties, as they’re rolling the dice and it could be devastating for one.

I’m not sure I und
VPLM
learningcurve2020 learningcurve2020 5 minutes ago
The arguments have all been laid out many times here so no need to go through it again. The real question now is whose side is time on anyway? I’d argue that every day gone by since about 2018 only confirms that the skeptics were right.
NWBO
ksquared ksquared 5 minutes ago
Today's news in a nutshell...
Everything is bad.
Nothing is good.
You're welcome.

Have a blessed Good Friday one and all.
Stks_Not_Toys Stks_Not_Toys 5 minutes ago
I received the voting info this morning.
RNAZ
redspeed redspeed 6 minutes ago
In summary, people are here for what MONI will be tomorrow, not what they were yesterday.

That's a good attitude and makes sense because what they did yesterday, last month or 9 months ago almost always gets cancelled, terminated or goes into the blank hole of nothingness.
MONI
ombowstring ombowstring 6 minutes ago
As tariffs darken the economic outlook, Trump sizes up Powell as a scapegoat

https://www.cnn.com/2025/04/18/politics/powell-trump-federal-reserve-tariffs/index.html

Donald Trump is showing why independent central banks are a good idea.

The president’s dou
ksquared ksquared 6 minutes ago
Morning, Mr. G. Funny... That was my silent reaction.
Didn't bother me one bit.
We're lucky to have Elon Musk on our side.
I wish him all the best.

Heat wave scheduled for tomorrow.
Put away the long johns and have your shorts on standby.
nowwhat2 nowwhat2 8 minutes ago
David Frum is the son of a well known American born Canadian journalist Barbara Frum who passed away in 1992. The Frums are a good example of the strong cultural ties between Canada and the US


https://www.youtube.com/watch?v=IQ7I2AbfPNY
ge11 ge11 8 minutes ago
Josh Funk who wrote the article was at the Investor meeting NioCorp had at the mine site probably 3 or so years ago.
NB
Gmenfan Gmenfan 8 minutes ago
“We’re Going With the Black Person… NO MATTER WHAT”

https://x.com/JamesOKeefeIII/status/1912944571878629773?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1912944571878629773%7Ctwgr%5Eae6a642a44f984f0223f6b041d17c30db138e8f0%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Finvestorshub.ad
pennybiteme pennybiteme 9 minutes ago
dunnno
APTY
Doc328 Doc328 9 minutes ago
I haven't heard or seen anything new. But, perhaps Cpap is referring to a recommendation to withdraw application? Would be better than an outright rejection. This would align with my thoughts since Dec 2022 that Missling should initiate and complete an appropriate P3 before submitting. Fortuna
AVXL
facts_matter14 facts_matter14 9 minutes ago
Hysterical! Did you notice that for possibly the first time in 2 years there was no BSR update on a given day yesterday??

She must really be taking this Acer thing hard.








.
SRMX

Your Recent History

NASDAQ
HURA
TuHURA Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads